Publicacions en què col·labora amb Juan Fernando García García (14)

2017

  1. Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets

    Oncotarget, Vol. 8, Núm. 67, pp. 111386-111395

2014

  1. Evaluación sistemática de la biopsia de médula ósea en casos de sospecha de mielofibrosis primaria. Propuesta de informe diagnóstico estandarizado. Consenso de expertos de las SEAP/SEHH

    Revista Espanola de Patologia

  2. Pathology reporting of bone marrow biopsy in myelofibrosis; application of the Delphi consensus process to the development of a standardised diagnostic report

    Journal of Clinical Pathology, Vol. 67, Núm. 7, pp. 620-625

  3. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

    Leukemia, Vol. 28, Núm. 6, pp. 1334-1340

2013

  1. Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas

    Blood Cancer Journal, Vol. 3, Núm. 4

  2. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

    British Journal of Haematology, Vol. 162, Núm. 3, pp. 336-347

  3. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64

2010

  1. Aggressive large B-cell lymphoma with plasma cell differentiation: Immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

    Haematologica, Vol. 95, Núm. 8, pp. 1342-1349

  2. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

  3. Intrafollicular neoplasia/in situ follicular lymphoma: Review of a series of 13 cases

    Histopathology

2006

  1. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma

    Blood, Vol. 108, Núm. 2, pp. 662-668

2005

  1. FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma

    Leukemia, Vol. 19, Núm. 12, pp. 2247-2253

2004

  1. Variability in the degree of expression of phosphorylated IκBα chronic lymphocytic leukemia cases with nodal involvement

    Clinical Cancer Research, Vol. 10, Núm. 20, pp. 6796-6806

2003

  1. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: Analyses using tissue microarrays

    Blood, Vol. 101, Núm. 2, pp. 681-689